Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma

Detaylı Bibliyografya
Asıl Yazarlar: Jing Tang, Yue Li, Jiazhu Wu, Haorui Shen, Hua Yin, Jinhua Liang, Li Wang, Jianyong Li, Yi Xia, Wei Xu
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: KeAi Communications Co., Ltd. 2024-03-01
Seri Bilgileri:Genes and Diseases
Online Erişim:http://www.sciencedirect.com/science/article/pii/S2352304223002039